Effect of cardiovascular risk factors on left ventricular ejection fraction in HER2 positive breast cancer patients who were treated in adjuvant setting with trastuzumab
Early microcirculation impairment in a pig model of anthracycline cardiotoxicity: evaluation by cardiac magnetic resonance and coronary physiology assessment